Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

In this page

Clinical Trial

NCT02110225 Completed
LUMOS

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy ofrhNGF in Patients With Retinitis Pigmentosa (RP)

Phase 1
Interventional

Disease

Disease type

Retinitis Pigmentosa

Orphan drug recognition

NA

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/01/2014

Closing date

01/11/2015

Inclusion criteria :

More

Exclusion criteria :

More

Funding

industry

Members involved

Main investigators

Dr Andrea SODI

Italy

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Retinal Rare Eye Diseases (WG1)
See more

Others investigators

Dr Giacomo Maria Bacci

Substitute

Italy

Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Pediatric Ophthalmology Rare Diseases (WG3), Retinal Rare Eye Diseases (WG1)
See more

Pr Luca Rossetti

Representative

Italy

See more

Pr Benedetto Falsini

Representative

Italy

See more

ERN EYE member investigating site

HCP : Principal investigators